Von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis

ASAIO Journal

Volumn 58, Issue 2, 2012, Pages 163-169

  Tsai, Han Mou ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTIC STENOSIS; COMPLEX MOLECULES; VENTRICULAR ASSIST DEVICE; VON WILLEBRAND FACTOR;

BIOMATERIALS; BIOPHYSICS;

SHEAR STRESS;

ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; VON WILLEBRAND FACTOR;

ANIMAL; BLOOD CLOTTING DISORDER; HEMOSTASIS; HUMAN; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOSIS;

ADAM PROTEINS; ANIMALS; BLOOD COAGULATION DISORDERS; HEMOSTASIS; HUMANS; STRESS, MECHANICAL; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84858155345     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31824363e7     Document Type: Conference Paper

References (41)

1. Sadler JE: New concepts in von Willebrand disease. Annu Rev Med 56: 173-191, 2005.
2. Tsai HM: Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 91: 1-19, 2010.
3. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM: Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A 87: 6306-6310, 1990.
4. Tsai HM, Sussman II, Nagel RL: Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 83: 2171-2179, 1994.
5. Tsai HM, Nagel RL, Hatcher VB, Sussman II: Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73: 2074-2076, 1989.
6. Tsai HM, Lian EC: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339: 1585-1594, 1998.
7. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE: Shear-dependent changes in the threedimensional structure of human von Willebrand factor. Blood 88: 2939-2950, 1996.
8. Themistou E, Singh I, Shang C, Balu-Iyer SV, Alexandridis P, Neelamegham S: Application of fluorescence spectroscopy to quantify shear-induced protein conformation change. Biophys J 97: 2567-2576, 2009.
9. Schneider SW, Nuschele S, Wixforth A, et al: Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A 104: 7899-7903, 2007.
10. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ: Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 108: 1903-1910, 2006.
11. Singh I, Themistou E, Porcar L, Neelamegham S: Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. Biophys J 96: 2313-2320, 2009.
12. Weiss HJ, Turitto VT, Baumgartner HR: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 92: 750-764, 1978.
13. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD: Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71: 1366-1374, 1988.
14. Goto S, Ikeda Y, Saldívar E, Ruggeri ZM: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101: 479-486, 1998.
15. Savage B, Saldívar E, Ruggeri ZM: Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84: 289-297, 1996.
16. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA: Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 324: 1330-1334, 2009.
17. Levy GG, Nichols WC, Lian EC, et al: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413: 488-494, 2001.
18. Bonnefoy A, Daenens K, Feys HB, et al: Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 107: 955-964, 2006.
19. Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA: Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105: 1085-1093, 2005.
20. Tsai HM, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL: Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1. Blood 89: 1954-1962, 1997.
21. O'Brien LA, Sutherland JJ, Hegadorn C, et al: A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers. J Thromb Haemost 2: 1135-1142, 2004.
22. Hassenpflug WA, Budde U, Obser T, et al: Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis. Blood 107: 2339-2345, 2006.
23. Stahl AL, Sartz L, Karpman D: Complement activation on plateletleukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117: 5503-5513, 2011.
24. Morigi M, Galbusera M, Gastoldi S, et al: Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187: 172-180, 2011.
25. Tsai HM, Chandler WL, Sarode R, et al: Von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49: 653-659, 2001.
26. Pareti FI, Lattuada A, Bressi C, et al: Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 102: 1290-1295, 2000.
27. O'Brien JR, Tsai HM, Etherington MD: Defective von willebrand factor activity detected by the filterometer in three clinical conditions. Platelets 11: 388-394, 2000.
28. Vincentelli A, Susen S, Le Tourneau T, et al: Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 349: 343-349, 2003.
29. Yoshida K, Tobe S, Kawata M, Yamaguchi M: Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 81: 490-494, 2006.
30. Love JW: The syndrome of calcific aortic stenosis and gastrointestinal bleeding: Resolution following aortic valve replacement. J Thorac Cardiovasc Surg 83: 779-783, 1982.
31. Natorska J, Bykowska K, Hlawaty M, Marek G, Sadowski J, Undas A: Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis. Heart 97: 2023-2028, 2011.
32. Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG: Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 17: 272-286, 2003.
33. Sucker C: The Heyde syndrome: Proposal for a unifying concept explaining the association of aortic valve stenosis, gastrointestinal angiodysplasia and bleeding. Int J Cardiol 115: 77-78, 2007.
34. Bhutani MS, Gupta SC, Markert RJ, Barde CJ, Donese R, Gopalswamy N: A prospective controlled evaluation of endoscopic detection of angiodysplasia and its association with aortic valve disease. Gastrointest Endosc 42: 398-402, 1995.
35. Budde U, Bergmann F, Michiels JJ: Acquired von Willebrand syndrome: Experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost 28: 227-238, 2002.
36. Velik-Salchner C, Maier S, Innerhofer P, et al: An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: The results of a pilot study. Anesth Analg 108: 1747-1754, 2009.
37. Crow S, Milano C, Joyce L, et al: Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J 56: 441-445, 2010.
38. Crow S, John R, Boyle A, et al: Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 137: 208-215, 2009.
39. Uriel N, Pak SW, Jorde UP, et al: Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 56: 1207-1213, 2010.
40. Hayes HM, Dembo LG, Larbalestier R, O'Driscoll G: Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: A single-center experience. Artif Organs 34: 703-706, 2010.
41. Frazier OH, Myers TJ, Westaby S, Gregoric ID: Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: Physiologic implications and their relationship to patient selection. Ann Thorac Surg 77: 133-142, 2004.